HOME >> BIOLOGY >> NEWS
Further Proof That An Altered Rb-2/p130 Gene Leads To Lung Cancer

Cancer researchers at Jefferson Medical College, Philadelphia, are gathering further evidence that damage to the human retinoblastoma-related gene, Rb-2/p130, a powerful tumor-suppressor, may lead to lung cancer.

They had previously suggested that damage to the Rb gene from cigarette smoke, air pollution and other toxins may lead to lung cancer. Such damage prevented the gene from making a key protein, pRb-2/p130, which suppresses tumor formation. They also saw evidence that levels of the protein correlated with tumor aggressiveness. This new work strengthens that finding.

“We looked at 158 lung cancer patient samples, and saw a strong correlation between low levels of the protein and aggressive and metastasizing lung cancer,” said Antonio Giordano, M.D., Ph.D., associate professor of pathology, anatomy, and cell biology, who led the work.

The research may lead to a new lung cancer tumor-grading test to enable physicians to determine how much Rb-2/p130 protein is found in individual lung cancer patients. This information can help physicians begin treatments earlier, and tailor them to specific patients, depending on how aggressive the cancer is.

“Now a tumor grading test is much closer to reality,” said Giordano, who is also president of the Sbarro Institute for Cancer Research and Molecular Medicine, which is affiliated with the college.

Of particular importance, he noted, was the strong relationship between protein levels and the amount that the cancer spread. "We not only found the confirming relationship between aggressiveness of the tumor and decreasing Rb2 protein, but also with the degree of metastasis," he said. Giordano and his colleagues at Jefferson and at the Second University of Naples report their findings in the October i
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-5291
Thomas Jefferson University
3-Oct-1997


Page: 1 2 3

Related biology news :

1. Jefferson Scientists Find Further Proof Of Damage To The FHIT Gene In Breast Cancers
2. Study Furthers Understanding Of Critical Alzheimers Disease Gene
3. Scientists Find Further Global Warming Evidence In Temperature Reconstruction Study
4. First Study To Take Bacteria Directly From Patients Mouths Further Supports Possible Link Between Gum And Heart Disease
5. Scientists Urge Further Study Of Alarming Coral Reef Decline
6. Electron Accelerator Provides Unique Proof Of Gene Repair Process In Living Cells
7. Altered expression of key developmental genes underlies evolution of butterfly wing patterns
8. Altered protein involved in a novel link to Alzheimers disease
9. Altered state may be responsible for creating important brain chemicals
10. Genetically-Altered Crops Can Produce Tough, Hard-To-Kill Weeds
11. Gene-Altered Mice Boost Studies of Cardiomyopathy: Enables Research Into Causes And Treatment Of Heart Failure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/9/2019)... ... April 09, 2019 , ... The McLeod Center for ... following a rigorous and voluntary audit conducted by an independent, third-party panel of ... Novalis Certified Centers in the United States, McLeod is the only such cancer center ...
(Date:4/4/2019)... GALWAY, Ireland (PRWEB) , ... April 02, 2019 ... ... discovery, development and commercialization of first-in-class stromal cell immunotherapies, announced it will move ... to become the anchor tenant at the University’s newly created biotechnology park in ...
(Date:4/4/2019)... , ... April 03, 2019 , ... ... stem cell therapies performed at its nationwide Centers of Excellence. R3 wants patients ... cell therapy provider. , To protect patients from Centers that use inferior regenerative ...
Breaking Biology News(10 mins):
(Date:4/10/2019)... ... April 10, 2019 , ... ... locked into multiple agreements to help companies advance their innovations to clinical ... ranging from synthetic biology companies that are gene editing therapeutic cells for ...
(Date:4/9/2019)... ... 09, 2019 , ... USDM Life Sciences , the ... organizations to accelerate innovation and maximize productivity, announces that nearly 100 companies have ... , USDM’s Cloud Assurance is a managed subscription service delivering end-to-end ...
(Date:4/9/2019)... ... April 09, 2019 , ... The American Society of Gene & ... leadership team, including a new addition to the presidential line of succession, at the ... join the Society's leadership team for a three-year term (2019-2021). , All five incoming ...
(Date:4/8/2019)... SAN FRANCISCO (PRWEB) , ... April 08, 2019 , ... ... to accredited investors a $15 million preferred equity investment in the privately held pharmaceutical ... dysfunction. Its leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and ...
Breaking Biology Technology:
Cached News: